Grant: Fellowship - Priority Announcement: Aging
Direct Payment
$150,000.00
Bitter-sweet role of glucose: Uncovering the dynamic of transient hyperglycemia-mediated longevity.
FY 2021-22
Summary
Hyperglycemia (high glucose concentration) is associated with metabolic and age-related disorders. Chronic hyperglycemia is responsible for insulin resistance, obesity, hypertension, and neuropathies, leading to tissue damage and fatal outcomes. However, glucose is not a toxic molecule per se. Its metabolic function is critical to fuel cellular processes involved in cell defenses and is crucial for the appropriate development of any living organism. Indeed, the metabolic efficacy of a cell profoundly influences how long and how well it endures the different stress encountered during its lifetime. Our initial work has shown that a short high-glucose diet during development can increase health and life in the nematode Caenorhabditis elegans. This 1 mm long worm is a uniquely powerful model organism to investigate metabolic processes in the context of aging. Its short life (about 21 days) and simple genetic have helped answer numerous questions in the context of aging. The proposed research focuses specifically on determining how glucose can enhance cellular resistance to metabolic and age-associated dysfunctions and the mechanisms underlying such protective responses. I will use an integrative approach relying on profiling both the transcriptome and metabolome of glucose-treated worms to provide a comprehensive picture of the mechanisms responsible for the glucose-mediated health response. Furthermore, we also attempt to describe when these protective mechanisms are lost and the potential targets with a therapeutic potential to reduce the incidence of metabolic and age-related disorders. The expected outcomes are a better understanding of the cellular, and the metabolic, components with therapeutic potential in the context of aging-related disorders such as Alzheimer's and Parkinson's Disease or Type II diabetes.
Department
Program
Fellowship - Priority Announcement: Aging
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
459577
Name
Tauffenberger Arnaud
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Bitter-sweet role of glucose: Uncovering the dynamic of transient hyperglycemia-mediated longevity.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Aging
Keyworddelim
Aging; Biochemistry; C. Elegans; Energy Metabolism; Fluorescence Microscopy; Glucose; Healthspan; Metabolomic; Proteostasis; Transcriptomic
Abstract
Hyperglycemia (high glucose concentration) is associated with metabolic and age-related disorders. Chronic hyperglycemia is responsible for insulin resistance, obesity, hypertension, and neuropathies, leading to tissue damage and fatal outcomes. However, glucose is not a toxic molecule per se. Its metabolic function is critical to fuel cellular processes involved in cell defenses and is crucial for the appropriate development of any living organism. Indeed, the metabolic efficacy of a cell profoundly influences how long and how well it endures the different stress encountered during its lifetime. Our initial work has shown that a short high-glucose diet during development can increase health and life in the nematode Caenorhabditis elegans. This 1 mm long worm is a uniquely powerful model organism to investigate metabolic processes in the context of aging. Its short life (about 21 days) and simple genetic have helped answer numerous questions in the context of aging. The proposed research focuses specifically on determining how glucose can enhance cellular resistance to metabolic and age-associated dysfunctions and the mechanisms underlying such protective responses. I will use an integrative approach relying on profiling both the transcriptome and metabolome of glucose-treated worms to provide a comprehensive picture of the mechanisms responsible for the glucose-mediated health response. Furthermore, we also attempt to describe when these protective mechanisms are lost and the potential targets with a therapeutic potential to reduce the incidence of metabolic and age-related disorders. The expected outcomes are a better understanding of the cellular, and the metabolic, components with therapeutic potential in the context of aging-related disorders such as Alzheimer's and Parkinson's Disease or Type II diabetes.
Competitiondate
202110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tauffenberger, Arnaud
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~